Caprotec | GenomeWeb

Caprotec

While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Movers & Shakers

Premium

Olink Bioscience this week appointed Simon Fredriksson as its new president and CEO, replacing Bjorn Ekstrom, who has led the company since its founding in 2004 and will be joining its board of directors.

Movers & Shakers

Premium

Gregory Critchfield, Ian Pike, Rainer Metternich

New Products

Premium

Caprotec

The company said that protein targets binding specifically to the drug in question showed activity in pathways commensurate with the drug candidate's phenotypic profile.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.